Statera Biopharma, Inc.

CIK 1318641 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Statera Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Mar 3, 202325-NSE0001354457-23-000149
Mar 1, 2023DEFR14A0001140361-23-009281
Feb 27, 2023DEF 14A0001140361-23-008695
Feb 14, 2023PRE 14A0001140361-23-007057
Feb 1, 20238-A12G0001437749-23-002250
Feb 1, 20238-K0001437749-23-002260
Jan 20, 20238-K0001437749-23-001440
Nov 28, 2022DEF 14A0001140361-22-043298
Nov 18, 2022PRE 14A0001140361-22-042212
Nov 15, 20228-K0001437749-22-027404
Nov 14, 202210-Q0001437749-22-027371
Nov 7, 20228-K0001437749-22-026090
Nov 7, 2022D0001437749-22-026086
Oct 28, 202210-Q0001437749-22-025006
Oct 27, 20228-K0001437749-22-024960
Oct 24, 20228-K0001437749-22-024547
Oct 21, 202210-Q0001437749-22-024497
Oct 17, 20228-K0001437749-22-024253
Oct 6, 202210-K0001437749-22-023703
Sep 27, 20228-K0001437749-22-023100
Sep 23, 20228-K/A0001437749-22-022934
Sep 9, 20228-K0001437749-22-022082
Aug 3, 20228-K0001437749-22-018609
Jun 22, 20228-K0001437749-22-015596
Jun 6, 20228-K0001437749-22-014427